Brighter
Kista
About Brighter
Data-driven solutions for smarter treatment of chronic conditions. Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Tackling diabetes first. Brighter is currently focused on treating the global diabetes epidemic by launching Actiste® Diabetes Management as a Service. https://actiste.com/ The Actiste device is based on patented technology for the remote monitoring and collection of data on specified bio-markers and volumes of medication injected. We believe this data-centric approach is key to providing smarter care for both diabetes and other chronic conditions too. Why Actiste? A video explaining the diabetes care service Actiste: https://youtu.be/qLWfTUbl3eM Brighter’s business model includes out-licensed rights to its platform. A business-critical part of Brighter’s operations involves continuous IP portfolio development’via its own applications and in-licensing (for example, the micro-needle technology in-licensing that Brighter acquired for blood sugar monitoring).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $16.8M
- Funding stage: IPO
- Last round: Post-IPO Debt (Aug 2022)
- Ticker: nasdaq:BRIG
- Website: brighter.se
- Phone: +468 550 088 20
Industries & Categories
Biotechnology, Health Care, Information Technology, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/brighter-225295 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.